Jade Biosciences (JBIO) Other Working Capital Changes (2020 - 2026)
Jade Biosciences (JBIO) posted Other Working Capital Changes of -$5.4 million for Q1 2026, down 153.38% on a QoQ basis from $10.2 million in Q4 2025, and down 1173.77% year-over-year from $507000.0 in Q1 2025.
Jade Biosciences (JBIO) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Jade Biosciences' Other Working Capital Changes history runs 2 years deep, the most recent figure standing at -$29000.0 for Q1 2026.
- Quarterly Other Working Capital Changes fell 1173.77% year-over-year to -$5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (up 65.33% YoY) and the FY2025 annual result came in at $12.0 million, up 4103.01% from the prior year.
- Other Working Capital Changes was -$5.4 million for Q1 2026 at Jade Biosciences, down from $10.2 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $10.2 million in Q4 2025 and bottomed at -$5.4 million in Q1 2026.
- A 5-year average of $388823.5 and a median of $265000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2025 — Other Working Capital Changes soared 3748.3% — and 2026, when it sank 1173.77%.
- Jade Biosciences' Other Working Capital Changes stood at -$28000.0 in 2025, then fell by 3.57% to -$29000.0 in 2026.
- Business Quant data shows JBIO's Other Working Capital Changes at -$29000.0 in Q1 2026, -$28000.0 in Q4 2025, and $9000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.44 Mn |
| Mar 31, 2026 | -5.44 Mn |
| Mar 31, 2026 | -5.44 Mn |
| Dec 31, 2025 | 10.20 Mn |
| Dec 31, 2025 | 10.20 Mn |
| Dec 31, 2025 | 10.20 Mn |
| Sep 30, 2025 | 413,000.00 |
| Sep 30, 2025 | 413,000.00 |
| Sep 30, 2025 | 413,000.00 |
| Jun 30, 2025 | 851,000.00 |
| Jun 30, 2025 | 851,000.00 |
| Jun 30, 2025 | 851,000.00 |
| Mar 31, 2025 | 507,000.00 |
| Mar 31, 2025 | 507,000.00 |
| Mar 31, 2025 | 507,000.00 |
| Dec 31, 2024 | 265,000.00 |
| Dec 31, 2024 | 265,000.00 |
| Dec 31, 2024 | 265,000.00 |
| Sep 30, 2024 | 215,000.00 |
| Sep 30, 2024 | 215,000.00 |